Ultragenyx Pharmaceutical | RARE - Market Capitalization

Stock Price
24.59
Daily Change
-0.21 -0.85%
Monthly
6.40%
Yearly
-45.80%
Q1 Forecast
23.33

Ultragenyx Pharmaceutical reported $2.04B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.6B 10M Sep/2025
Agios Pharmaceuticals USD 2.33B 402M Sep/2025
Alnylam Pharmaceuticals USD 59.77B 17.25B Sep/2025
BioMarin Pharmaceutical USD 10.4B 142M Sep/2025
Insmed USD 30.44B 11.35B Sep/2025
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
Kyowa Hakko Kirin JPY 1.21T 87.78B Sep/2025
MacroGenics USD 114M 8M Feb/2026
Moderna USD 10.09B 581M Sep/2025
Neurocrine Biosciences USD 13.92B 1.48B Sep/2025
PTC Therapeutics USD 4.88B 1B Sep/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Sarepta Therapeutics USD 2.02B 336M Sep/2025
Ultragenyx Pharmaceutical USD 2.9B 539M Sep/2025
Vertex Pharmaceuticals USD 100.41B 13.91B Sep/2025